Australian Scientists Develop New Stem Cell Heart Therapy
澳洲科學家研發出新型幹細胞心臟療法
Australian scientists are spearheading a medical revolution with new stem cell therapies designed to repair damaged heart tissue.
澳洲科學家正引領一場醫學革命，研發出旨在修復受損心臟組織的新型幹細胞療法。
Cardiovascular disease remains the leading cause of death globally, but current treatments like heart transplants are hindered by organ shortages and high costs.
心血管疾病仍是全球首要死因，但現有的心臟移植等治療手段受限於器官短缺與高昂費用。
In March 2026, the biotech company Ibnova Therapeutics was launched to advance stem cell treatments into human clinical trials within the next five years.
2026年3月，生技公司Ibnova Therapeutics成立，旨在於未來五年內推動幹細胞治療進入人體臨床試驗。
Researchers such as Professor Enzo Porrello and Professor James Hudson have successfully used lab-grown heart muscle in animal models to restore function.
Enzo Porrello教授和James Hudson教授等研究人員已成功將實驗室培育的心肌應用於動物模型以恢復功能。
A major obstacle has been the risk of abnormal heart rhythms, or arrhythmias.
一大障礙是心律不整（ㄉㄧㄢˋ）的風險。
However, Professor James Chong's team recently identified ways to isolate safe cells and control these rhythms, paving the way for safer procedures.
然而，James Chong教授的團隊近期找到分離安全細胞並控制心律的方法，為更安全的術程鋪平道路。
Furthermore, researchers at the University of Technology Sydney are innovating with 3D-bioprinted heart patches made from a patient's own cells.
此外，雪梨科技大學的研究人員正透過患者自身細胞製成的3D生物列印心臟補片進行創新。
